Genomic studies to unlock
the truth of active compounds
Genel provides pharmaceutical and cosmetic companies
with new services to enhance personalized care.
Genel proposes innovative approach:
using 3D cellular models and primary cells to highlight active ingredient effects on its gene target
combining bioscreening, new imaging system and bioinformatics to guarantee an effective, fast, reliable and ready-to-use result
GENEL présente à ADEBIOTECH 2018
Romainville-Grand Paris | 13-14 March 2018
Gaëlle Saint-Auret présente à ADEBIOTECH les 13 et 14 Mars prochain. Elle y discutera des outils d'intérêt pour l'étude de l'épigénétique.
genel at In-Cosmetics
London, UK | 4-6 April 2017
Let us meet at ExCel London! The genel team will be present at this major event and hope to meet you there!
Genel’s contribution to research and development of RNA therapy was recognised in the LEEM’s report on Biotech/Innovations in healthcare!
20 October 2016
Read how our strong potential is predicted to strengthen the biotechnology competitivity in France for the next three years, we hope to live up to these...
GENEL and BASF granted a podium session in New York
Grenoble | 21 March 2018
BASF presented results of another fruitful collaboration with GENEL at the podium sessions of the 71st Annual Scientific Meeting & Technology Showcase in New...
GENEL and BASF partnership still going strong
Grenoble | 21 March 2018
GENEL and long-time partner BASF have been busy in 2017! Our latest innovative research was showcased at the poster session of the 24th IFSCC in Seoul. The...
GENEL featured in the "Journal des Entreprises"
Grenoble | 9 June 2017
GENEL was cited in the "Journal des Entreprises" as a contributor of the biotech hub of grenoble for our research in the oncology department! Read the article...
The key to performance
